Moderna president says kids could be vaccinated ‘going into the school year’
Moderna President Dr. Stephen Hoge issued more details about the COVID-19 vaccine trials for children
Moderna president Dr. Stephen Hoge said on the “Today” show Wednesday that children could be vaccinated “going into the school year.”
- Children who are aged 6 months to 1 year old will get two doses of the Moderna COVID-19 vaccine over a 28-day period at either 25, 50 or 100 microgram levels.
- The trial will include children from 2 to 11 years old, who will receive two doses over 28 days at either the 50 or 100 microgram level.
When will children get vaccinated?
Hoge said his company is currently conducting trials for the Moderna COVID-19 vaccine on children. Details of the trials are expected soon.
- “We expect to have data from that 12 to 17 (year-old) TeenCove study, hopefully perhaps by the summer, so we could be vaccinating adolescents going into the school year,” he told Today.com. “The KidCove trial, 6-month-olds to 12-year-olds, is going to take a little longer … it’ll probably take the better part of this year to complete.”
And so far, the signs look good, he said.
“We certainly haven’t seen anything concerning in prior work that would suggest we can’t use the vaccine in children.”